Company profilePharmaceutical#1106 of 1,318 in Pakistan✓ No DRAP alerts

RA Healthcare (SMC-Pvt) Ltd DSL: 01-374-0176-99719D

Pharmaceutical company · 2 brands · 3 molecules

2 registered products 3 pharmaceutical brands 3 distinct molecules 0 DRAP alerts

Company overview

2
registered products
3
pharmaceutical brands
3
distinct molecules
0
therapeutic classes
0
DRAP alerts

RA Healthcare (SMC-Pvt) Ltd DSL: 01-374-0176-99719D is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 2 product registrations across 3 distinct molecules. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by RA

5 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

5
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
20252
20263

Top molecules by brand count

Isoflurane ...... 100 Ml1 brand
Isoflurane ...... 100 % V1 brand
Bevacizumab ...... 100Mg1 brand

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official3 products · Rs 4,357.79 – Rs 17,674.07
Median across source: Rs 10,134.44

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Biocare Pharmaceutica DSL: 05-353-0063-032069D holds 12 molecules not in this portfolio
Azithromycin 250MgAzithromycin 500MgFluconazoleInterferon Alpha 2B 5MiuMicroemulsion Cyclosporin AMicroemulsion Cyclosporin A 100Mg
Allied Distributors DSL: 0325 holds 3 molecules not in this portfolio
CeftazidimePropofolSevoflurane
The Searle Company Limited holds 14 molecules not in this portfolio
AmoxicillintrihydrateequivalenttoamoxcillinbaseAmoxicillintrihydrateequivalenttoamoxicillinbaseBudesonide400McgBupivacaineBupropionCefixime

Get the full profile for RA

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.